Similar Articles
Screening and identification of potential biomarkers and therapeutic targets for systemic sclerosis-associated interstitial lung disease
Biqing Huang, Jing Li, Jiuliang Zhao
DOI: 10.46497/ArchRheumatol.2021.8625
Patient perspectives on biological treatments for inflammatory arthritis: A multi-center study in Korea
In Ah Choi, Ji Hyoun Kim, Sung Hae Chang, Ran Song, You-Jung Ha, Hye Won Kim, Jeong Seok Lee, Byoongyong Choi, Yoon-Jeong Oh, Ki Won Moon
DOI: 10.46497/ArchRheumatol.2021.8524
Peer-led education or booklet for knowledge transfer about disease: A randomized-controlled trial with ankylosing spondylitis patients
Taciser Kaya, Pınar Atıcı, Altınay Göksel Karatepe, Rezzan Günaydın
DOI: 10.46497/ArchRheumatol.2021.8334
Clinical and serological characteristics of systemic sclerosis: Experience of a tertiary care center in Pakistan
Sadia Asif, Asadullah Khan, Muhammad Faiq, Zia Ud Din, Sarmad Zahoor, Muhammad Haroon
DOI: 10.46497/ArchRheumatol.2021.8701
Relationship between diet, oxidative stress, and inflammation in ankylosing spondylitis
Kübra Tel Adıgüzel, Fatma Gül Yurdakul, Nilgün Seremet Kürklü, Evren Yaşar, Hatice Bodur
DOI: 10.46497/ArchRheumatol.2022.9015
Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
Ali Erhan Özdemirel, Serdar Can Güven, Zühre Sarı Sürmeli, Ayla Özyuvalı, Memet Kurt, Diana Rüstemova, Ayşe Peyman Yalçın Sayan, Hüseyin Tutkan, Şebnem Ataman
DOI: 10.46497/ArchRheumatol.2022.9819
Anti-tumor necrosis factor alpha treatment does not influence serum levels of the markers associated with radiographic progression in ankylosing spondylitis
Ali Erhan Özdemirel, Serdar Can Güven, Alper Doğancı, Zühre Sarı Sürmeli, Ayla Özyuvalı, Mehmet Kurt, Diana Rüstemova, Selin Hassan, Ayşe Peyman Yalçın Sayın, Hüseyin Tutkak, Şebnem Ataman
DOI: 10.46497/ArchRheumatol.2023.9974
Discovery of fecal microbial signatures in patients with ankylosing spondylitis
Yuquan You, Wei Zhang, Meimei Cai, Qingxin Guo, Jiawen Wang, Yaping Cai, Junsheng Lin
DOI: 10.46497/ArchRheumatol.2023.9124
Mevalonate kinase gene polymorphisms in ankylosing spondylitis patients: A cross-sectional study
Fatih Yıldız, Suzan Dinkçi, Eren Erken
DOI: 10.46497/ArchRheumatol.2023.9468
The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis
Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur
DOI: 10.46497/ArchRheumatol.2023.9636
Analysis of risk factors for the progression and prognosis of connective tissue disease-associated interstitial lung disease
Ting Zhao, Fu-an Lin, Hongpu Chen
DOI: 10.46497/ArchRheumatol.2023.9602
Aryl hydrocarbon receptor gene expression in ankylosing spondylitis and its correlation with interleukin-17, RAR-related orphan receptor gamma t expression, and disease activity indices
Maryam Ahmadi, Narjes Soleimanifar, Abdolrahman Rostamian, Maryam Sadr, Hanieh Mojtahedi, Abeda Mazari, Mohammad Hossein Nicknam, Sara Assadiasl
DOI: 10.46497/ArchRheumatol.2023.10203
Frequency of fibromyalgianess in patients with rheumatoid arthritis and ankylosing spondylitis: A multicenter study of Turkish League Against Rheumatism (TLAR) network
Erkan Kozanoğlu, Bayram Kelle, Gamze Alaylı, Ömer Kuru, Sibel Çubukçu Fırat, Ali Nail Demir, Mehmet Karakoç, Şüheda Özçakır, Zuhal Altay, İlknur Aktaş, Feyza Ünlü Özkan, Fikriye Figen Ayhan, Erhan Çapkın, Murat Karkucak, Taciser Kaya, Ülkü Uçar, Akın Erdal, Nurettin Taştekin, Esra Gizem Koyuncu, Elif Aydın, Ömer Faruk Şendur, İlker Ünal, Ayşen Akıncı
DOI: 10.46497/ArchRheumatol.2023.9925
Clinical association study on the matrix metalloproteinase expression in the serum of patients with connective tissue disease complicated with interstitial lung disease
Hong Chen*, Jun Tang*, Juhua Liang, Dan Huang, Chunfeng Pan, Sha Liu, Xiuri Du, Liju Tao
DOI: 10.46497/ArchRheumatol.2023.9547
Solitary syndesmophyte in odontoid process of a patient with ankylosing spondylitis
Hong Ki Min, Se Hee Kim, Hae-rim Kim, Sang-heon Lee
DOI: 10.46497/ArchRheumatol.2023.9880
Progressive pulmonary fibrosis in patients with connective tissue disease-associated interstitial lung disease: An explorative study
Jakob Höppner, Maximilian Wollsching-Strobel, Falk Schumacher, Wolfram Windisch, Melanie Berger
DOI: 10.46497/ArchRheumatol.2024.10105
Correlation between clinical disease activity and sacroiliac magnetic resonance imaging detection in axial spondyloarthropathy
Ozenc Inan, Ebru Aytekin, Yasemin Pekin Dogan, Ilhan Nahit Mutlu, Kübra Aydemir, Nuran Oz, Nil Sayiner Caglar
DOI: 10.46497/ArchRheumatol.2024.10401
Predictive risk factors for one-year mortality in idiopathic inflammatory myopathy patients with interstitial lung disease: A retrospective, single-center cohort study
Minna Jiang, Xiaohong Wen, Sisi Xia, Yiqun Guo, Yu Bai
DOI: 10.46497/ArchRheumatol.2024.10418
Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results
Sadettin Uslu, Semih Gülle, Özkan Urak, Gerçek Şen, Ediz Dalkılıç, Soner Şenel, Servet Akar, Nevsun İnanç, Ayşe Cefle, Aydan Köken Avşar, Servet Yolbaş, Sema Yılmaz, Özgül Soysal Gündüz, İsmail Sarı, Merih Birlik, Nurullah Akkoç, Fatoş Önen
DOI: 10.46497/ArchRheumatol.2024.10391
Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis
Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria
DOI: 10.46497/ArchRheumatol.2024.10199